Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1744-8603
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study ; volume:16 ; number:1 ; day:10 ; month:9 ; year:2020 ; pages:1-11 ; date:12.2020
Globalization and health ; 16, Heft 1 (10.9.2020), 1-11, 12.2020
- Classification
-
Wirtschaft
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12992-020-00610-2
- URN
-
urn:nbn:de:101:1-2020103019134731339191
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jung, Ye Lim
- Hwang, JeeNa
- Yoo, Hyoung Sun
- SpringerLink (Online service)
Other Objects (12)
Regulating pharmaceutical companies’ financial largesse
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry
XRM: integrated customer relationship management for pharmaceutical innovations
Leading pharmaceutical operational excellence : outstanding practices and cases
Leitbetriebe Steiermark : Edition 15 Jahre= Leading companies Styria
Innovations Through Mergers and Acquisitions in the Pharmaceutical Sector
Changing R&D models in research-based pharmaceutical companies
Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry ; with 20 tables
Social innovations in companies and in social economy enterprises
Evaluate the financial performance of pharmaceutical companies using fuzzy DEA
A Content Analysis of Whistleblowing Policies of Leading European Companies
Regulating pharmaceutical companies’ financial largesse
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry
XRM: integrated customer relationship management for pharmaceutical innovations
Leading pharmaceutical operational excellence : outstanding practices and cases
Leitbetriebe Steiermark : Edition 15 Jahre= Leading companies Styria
Innovations Through Mergers and Acquisitions in the Pharmaceutical Sector
Changing R&D models in research-based pharmaceutical companies
Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry ; with 20 tables
Social innovations in companies and in social economy enterprises
Evaluate the financial performance of pharmaceutical companies using fuzzy DEA
A Content Analysis of Whistleblowing Policies of Leading European Companies
Regulating pharmaceutical companies’ financial largesse
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry
XRM: integrated customer relationship management for pharmaceutical innovations
Leading pharmaceutical operational excellence : outstanding practices and cases
Leitbetriebe Steiermark : Edition 15 Jahre= Leading companies Styria
Innovations Through Mergers and Acquisitions in the Pharmaceutical Sector
Changing R&D models in research-based pharmaceutical companies
Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
Leading pharmaceutical innovation : trends and drivers for growth in the pharmaceutical industry ; with 20 tables
Social innovations in companies and in social economy enterprises
Evaluate the financial performance of pharmaceutical companies using fuzzy DEA